ISSN:
1432-0843
Source:
Springer Online Journal Archives 1860-2000
Topics:
Medicine
Notes:
Summary A total of 32 patients with advanced squamous-cell carcinoma of the cervix were treated with 300 mg/m2 i. v. carboplatin and 5 g/m2 ifosfamide as a 24-h i. v. infusion, both given on day 1 every 4 weeks. In all, 3 (9%) complete responses (CRs) and 19 (59%) objective responses (CR+PR) were achieved in 32 patients. Myelosuppression with leukopenia and/or thrombocytopenia of WHO grade 4 in 28% and 13% of patients, respectively, was the main toxicity. The results of our study suggest that carboplatin/ifosfamide is active as neoadjuvant treatment in advanced cervical cancer.
Type of Medium:
Electronic Resource
URL:
http://dx.doi.org/10.1007/BF00685414
Permalink